Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Richard Brown

Research Scientist

Ruhr-Universität Bochum

Germany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Articles (17)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (11)

Tran Tuoc

Ruhr-Universität Bochum

GERMANY

View details

Eike Steinmann

Ruhr-Universität Bochum

GERMANY

View details

Anne Balkema-Buschmann

Deputy head, Senior Scientist

Friedrich-Loeffler-Institut

GERMANY

View details

Dagmar Wirth

Head of Research Group

Helmholtz Centre for Infection Research

GERMANY

View details

Michael Muehlebach

Dept. Head of Division

Paul-Ehrlich-Institut

GERMANY

View details

Alexander Tarr

Associate Professor of Molecular Virology

University of Nottingham

UNITED KINGDOM

View details

Daniel Todt

Head

Ruhr-Universität Bochum

GERMANY

View details

Andre Goemer

Ruhr-Universität Bochum

GERMANY

View details

Stephanie Pfaender

Head of Research Unit

Ruhr-Universität Bochum

GERMANY

View details

Marek Widera

Group Leader

Klinikum der Johann Wolfgang Goethe-Universität Frankfurt

GERMANY

View details

Zoltan Ivics

Head of Department

Fraunhofer Institute for Cell Therapy and Immunology

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Richard Brown

Research Interests

Make your next move.

Explore related searches

Articles (17)

Viral entry defines the hepatitis E virus species barrier in murine hepatocytes

From discovery to therapy: The role of HSPB1 in HBV persistence

Mycophenolic acid treatment drives the emergence of novel SARS-CoV-2 variants

Seroprevalence of segmented flavi-like Alongshan virus in horses

Differential efficacy of first licensed western vaccines protecting without immunopathogenesis Wuhan-1-challenged hamsters from severe COVID-19

Adapted hepatitis C virus clone infects innate immunity-deficient mouse hepatocytes with minimal human HCV entry factors

From zoonotic spillover to endemicity: the broad determinants of human coronavirus tropism

Spatiotemporal analysis of SARS-CoV-2 infection reveals an expansive wave of monocyte-derived macrophages associated with vascular damage and virus clearance in hamster lungs

MicroRNAs modulate SARS‐CoV infection of primary human hepatocytes by regulating the entry factors ACE2 and TMPRSS2

TMPRSS2-mediated SARS- CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution

The glutamate receptor antagonist ifenprodil inhibits hepatitis E virus infection

Inactivation of yellow fever virus by WHO-recommended hand rub formulations and surface disinfectants.

Targeting cellular cathepsins inhibits hepatitis E virus entry

Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets

Unraveling the dynamics of hepatitis C virus adaptive mutations and their impact on antiviral responses in primary human hepatocytes

Productive infection of primary human hepatocytes with SARS-CoV-2 induces antiviral and proinflammatory responses

Mouse Liver-Expressed Shiftless Is an Evolutionarily Conserved Antiviral Effector Restricting Human and Murine Hepaciviruses

Collaborators (11)

Tran Tuoc

Eike Steinmann

Anne Balkema-Buschmann

Dagmar Wirth

Michael Muehlebach

Alexander Tarr

Daniel Todt

Andre Goemer

Stephanie Pfaender

Marek Widera

Zoltan Ivics

Make your next move.